Clinical Trial Update: Does Clinical Response Correlate With Serum Certolizumab Levels? [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update explores whether clinical response in Crohn's disease correlates with serum certolizumab pegol levels.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• CIMZIA (CERTOLIZUMAB PEGOL)

Snippet

Sponsor: Shafran Gastroenterology Center | Conditions: Crohn's Disease | Phase 4 | Status: UNKNOWN